
无国界医生组织表示,默克公司的埃博拉疫苗应在刚果(金)不断升级的疫情中更广泛地部署,理由是新出现的证据表明,该疫苗可能对其并非设计针对的病毒株提供保护。
Merck & Co.’s Ebola vaccine should be deployed more widely in the Democratic Republic of Congo’s escalating outbreak, Doctors Without Borders said, citing emerging evidence that the shot may provide protection against a virus it wasn’t designed to target.
Ervebo 是针对埃博拉扎伊尔株开发的,目前已在针对本次疫情罪魁祸首——邦迪布焦病毒的测试中使用,并已在研究和同情用药项目下接种给数千人。该医疗援助组织呼吁取消对其使用的限制,以便更多高危人群(包括幼童)能够接种疫苗。
Ervebo, developed against the Zaire strain of Ebola, is already being tested against the Bundibugyo virus responsible for the epidemic and has been administered to thousands of people under research and compassionate-use programs. The medical aid group is calling for restrictions on its use to be lifted so more people at risk, including young children, can be vaccinated.
无国界医生组织(又称 MSF,其法语缩写)表示,其团队观察到,在疫情爆发前接种过疫苗的人群中,确诊感染病例较少;而在接种过疫苗后仍被感染的人群中,死亡率有降低迹象。
Doctors Without Borders, also known by its French acronym MSF, said its teams have observed fewer confirmed infections among people vaccinated before the outbreak and indications of lower mortality among vaccinated people who became infected.
这些观察结果并不能确立 Ervebo 对邦迪布焦病毒有效,但增加了实验室和动物实验证据,提示它可能提供一定的交叉保护。
The observations don’t establish that Ervebo is effective against Bundibugyo, but add to laboratory and animal evidence suggesting it may offer some cross-protection.
“无国界医生组织认为,缺乏针对邦迪布焦病毒的专用疫苗,不应阻碍目前唯一可用疫苗的使用,”该组织流行病学家、运营副主任 Guyguy Manangama 周二在声明中说。
“For MSF, the absence of a Bundibugyo-specific vaccine should not prevent the use of the only vaccine currently available,” Guyguy Manangama, an epidemiologist and deputy director of operations at MSF, said in a statement Tuesday.
这一问题对儿童尤为迫切。本次疫情中,约十分之七的五岁以下确诊儿童死亡,而 Ervebo 获批用于一岁及以上人群,且具有既定的安全性概况。无国界医生组织表示,针对邦迪布焦病毒的实验性疫苗在儿童中的证据和潜在获取途径(针对 12 岁以下儿童)可能需要更长时间。
The question is particularly pressing for children. About seven in 10 children under five years of age confirmed with Ebola have died during the outbreak, while Ervebo is authorized for people aged one and older and has an established safety profile. Evidence and potential access for children under 12 to experimental vaccines specifically targeting Bundibugyo may take longer, MSF said.
世界卫生组织上周表示,牛津大学和莫德纳公司开发的两款针对邦迪布焦病毒的疫苗,在获得国家批准后将加入正在进行的“图迈尼”试验。据非洲疾病控制与预防中心支持,刚果(金)于8月向国际埃博拉疫苗储备库申请了50万剂“厄博韦”疫苗。无国界医生组织称,仅有7万剂获批释放,更大规模的释放将取决于世卫组织疫苗咨询小组下周开会时的背书。
Two Bundibugyo-specific vaccines developed by Oxford University and Moderna Inc. are set to join the ongoing Tumaini trial following national approvals, the World Health Organization said last week Congo, backed by the Africa Centres for Disease Control and Prevention, requested 500,000 Ervebo doses from the international Ebola vaccine stockpile in August. Only 70,000 were released, according to MSF, which said a larger release would be subject to endorsement by WHO’s vaccine advisory group when it meets next week.
据政府最新疫情报告,截至11月7日,刚果(金)累计确诊感染10,920例,死亡5,323例。这场疫情是该国有记录以来规模最大的埃博拉疫情,也是全球第二大埃博拉疫情。
Congo had recorded 10,920 confirmed infections and 5,323 deaths as of Nov. 7, according to the government’s latest outbreak report. The epidemic is the largest Ebola outbreak ever recorded in the country and the second largest globally.